ATTRACTION‐05 (ONO‐4538‐38/BMS CA209844): A randomized, multicenter, double‐blind, placebo‐ controlled Phase 3 study of Nivolumab (Nivo) in combination with adjuvant chemotherapy in pStage III gastric and esophagogastric junction cancer
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.